ABSTRACT
Chlamydia psittaci is an obligate intracellular zoonotic pathogen that can enter a persistence state in host cells. While the exact pathogenesis is not well understood, this persistence state may play an important role in chronic Chlamydia disease. Here, we assess the effects of chlamydial persistence state in vitro and in vivo by transmission electron microscopy (TEM) and cDNA microarray assays. First, IFN-γ-induced C. psittaci persistence in HeLa cells resulted in the upregulation of 68 genes. These genes are involved in protein translation, carbohydrate metabolism, nucleotide metabolism, lipid metabolism and general stress. However, 109 genes were downregulated following persistent C. psittaci infection, many of which are involved in the TCA cycle, expression regulation and transcription, protein secretion, proteolysis and transport, membrane protein, presumed virulence factor, cell division and late expression. To further study differential gene expression of C. psittaci persistence in vivo, we established an experimentally tractable mouse model of C. psittaci persistence. The C. psittaci-infected mice were gavaged with either water or amoxicillin (amox), and the results indicated that the 20 mg/kg amox-exposed C. psittaci were viable but not infectious. Differentially expressed genes (DEGs) screened by cDNA microarray were detected, and interestingly, the results showed upregulation of three genes (euo, ahpC, prmC) and downregulation of five genes (pbp3, sucB_1, oppA_4, pmpH, ligA) in 20 mg/kg amox-exposed C. psittaci, which suggests that antibiotic treatment in vivo can induce chlamydial persistence state and lead to differential gene expression. However, the discrepancy on inducers between the two models requires more research to supplement. The results may help researchers better understand survival advantages during persistent infection and mechanisms influencing C. psittaci pathogenesis or evasion of the adaptive immune response.
Subject(s)
Chlamydophila psittaci/physiology , Psittacosis/metabolism , Amoxicillin/administration & dosage , Amoxicillin/therapeutic use , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Cytokines/genetics , Cytokines/metabolism , Dose-Response Relationship, Drug , Down-Regulation , Female , Gene Expression Regulation/physiology , Germ-Free Life , HeLa Cells , Humans , Mice , Mice, Inbred BALB C , Microscopy, Electron, Transmission , Psittacosis/drug therapy , Psittacosis/immunology , Psittacosis/microbiology , Transcriptome , Up-RegulationABSTRACT
OPINION STATEMENT: There is strong evidence to corroborate the association with Helicobacter pylori (Hp) to gastric extranodal marginal zone lymphoma (ENMZL) and hepatitis C virus (HCV) to splenic/nodal marginal zone lymphoma. Koch's postulates generally hold for these two associations and eradication of the infectious agent is well supported. Hp eradication (HPE) is recommended as front-line therapy for early stage gastric ENMZL regardless of Hp status. Complete response (CR) rate for Hp-negative patients is not as high as for Hp-positive patients; however, the benign nature of HPE and high rates of salvage allow this strategy to be safe while sparing some Hp-negative patients from systemic therapy or radiation. Similarly for HCV-seropositive patients, treatment with antivirals should be strongly considered as first-line for those who do not require immediate cytoreductive therapy or at some point even after completing chemoimmunotherapy. The controversy regarding the role for antibiotics is greatest for primary ocular adnexal lymphoma (POAL). Considering the low incidence of Chlamydia psittaci (Cp) infection with OAL and the challenges to reliably identifying Cp, we typically do not consider doxycycline in POAL treatment. Involved-field radiotherapy (IFRT) remains the treatment of choice for most with unilateral POAL. However, if reliable detection of Cp is available and Cp is identified, patients with unilateral low tumor stage POAL who do not require immediate radiotherapy could be considered for doxycycline as front-line treatment. Other infectious associations to indolent lymphomas have been made, including Borrelia borgdorferi (Bb) in cutaneous lymphoma and Campylobacter in immunoproliferative small intestinal disease (IPSID), but these associations are not as strong and primary treatment targeting the infectious agents is not recommended.
Subject(s)
Anti-Infective Agents/therapeutic use , Lymphoma, B-Cell, Marginal Zone/pathology , Lymphoma, B-Cell, Marginal Zone/therapy , Lymphoma/pathology , Lymphoma/therapy , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Campylobacter Infections/complications , Campylobacter Infections/drug therapy , Campylobacter Infections/microbiology , Helicobacter Infections/complications , Helicobacter Infections/drug therapy , Helicobacter Infections/microbiology , Hepatitis C/complications , Hepatitis C/drug therapy , Hepatitis C/virology , Humans , Lyme Disease/complications , Lyme Disease/drug therapy , Lyme Disease/microbiology , Lymphoma/etiology , Lymphoma, B-Cell, Marginal Zone/etiology , Neoplasm Grading , Psittacosis/complications , Psittacosis/drug therapy , Psittacosis/microbiologyABSTRACT
The in vitro and in vivo antichlamydial activities of HSR-903 were investigated. The MICs of HSR-903 for different species of chlamydia were 0.016 to 0.063 microg/ml, which were superior to those of conventional fluoroquinolones. The therapeutic effect of HSR-903 in experimental mouse Chlamydia psittaci pneumonia was also excellent and almost equal to that of minocycline and superior to that of ofloxacin. These results indicate that HSR-903 may be useful in the treatment of respiratory infections caused by chlamydiae.
Subject(s)
Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Chlamydia/drug effects , Chlamydophila psittaci/drug effects , Fluoroquinolones , Psittacosis/drug therapy , Quinolones/pharmacology , Animals , Anti-Bacterial Agents/therapeutic use , HeLa Cells , Humans , Male , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , Minocycline/therapeutic use , Ofloxacin/therapeutic use , Psittacosis/microbiology , Quinolones/therapeutic useABSTRACT
Intracerebral inoculation of mice with the A22 strain of ovine C. psittaci gave a reproducible non-lethal infection; multiplication of the inoculum could be quantitated by titration of mouse brain extracts in tissue culture. Mice which had recovered from infection, or which had been inoculated subcutaneously with living organisms of A22 strain, showed solid resistance to intracerebral challenge infection. However, subcutaneous inoculation of formalin-inactivated chlamydia showed little protective effect unless given in very high dosage. Inactivated vaccines of the heterologous ZC113 strain gave better, but still incomplete, protection against A22 challenge infection than did the homologous inactivated vaccine. The implication of these findings is discussed. The mouse intracerebral protection test appears to be a suitable laboratory procedure for assessing the potency of vaccines against enzootic ewe abortion and for comparing the immunological cross-protection between the various strains of C. psittaci currently found in the natural disease in sheep.
Subject(s)
Brain Diseases/therapy , Immunotherapy , Psittacosis/therapy , Sheep/microbiology , Animals , Bacterial Vaccines/immunology , Brain Diseases/immunology , Brain Diseases/microbiology , Chlamydophila psittaci/immunology , Chlamydophila psittaci/isolation & purification , Drug Evaluation, Preclinical , Immunity , Mice , Mice, Inbred Strains , Psittacosis/immunology , Psittacosis/microbiologySubject(s)
Psittaciformes , Psittacosis/drug therapy , Animal Feed , Animals , Chlamydophila psittaci/isolation & purification , Chlortetracycline/administration & dosage , Doxycycline/administration & dosage , Drug Evaluation, Preclinical , Psittacosis/microbiology , Psittacosis/pathology , Time FactorsABSTRACT
The obligate intracellular procaryote Chlamydia psittaci replicated in cultures of macrophages taken from the peritoneal cavities of unstimulated or thioglycollate-elicited A/J mice. When treated with supernatant fluids (lymphokines) from C. psittaci-immune mice spleen cells that were stimulated for 24 hr in vitro by the mitogen concanavalin A, resident macrophages supplemented with heart infusion broth (8 mg/ml) and elicited macrophages markedly suppressed intracellular chlamydial development. Uptake of the parasites was unaffected by LK-activated macrophages. The LK-induced inhibition was a static rather than a cidal effect. Chlamydial replication was detected 24 to 41 hr after removal of LK and infection with C. psittaci. Evidence that intermediates of oxygen metabolism did not contribute to the microbistatic process in either resident or elicited macrophages was provided by the inability of exogenous catalase, deprivation of glucose, or pretreatment with phorbol myristate acetate (PMA) to reverse LK-induced inhibition of parasite replication.